Hindustan Unilever Ltd. share price target

ended June 2021 has increased 14% to Rs 12194 crore. Operating profit margin has slumped from 25.1% to 24%, leading to 8% rise in operating profit to Rs 2,921.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 33.79% to 30.51%. Purchase of finished goods cost rose from 15.15% to 18.51%. Employee cost decreased from 5.72% to 5.42%. Other expenses rose from 20.62% to 21.34%. Selling and administration expenses rose from 7.34% to 8.53%. Other income fell 57% to Rs 66 crore. Provision for interest fell 58% to Rs 13 crore. Provision for depreciation rose 1% to Rs 260 crore. Profit...

Consequent PAT was at | 2061 crore (up 9.6% YoY) five years (from ~| 922 in July 2016 to ~| 2388 levels in July 2021). We roll over FY24 numbers given Covid-19 related disruptions have temporarily impacted financials & FY23-FY4 would be a normalised year. We continue to remain positive and retain our BUY rating on the stock...

We maintain a BUY rating on the stock and value it at 50x FY24E EPS to arrive at a revised TP of Rs 2,670/share (from earlier Rs 2,650/share).

Hindustan Unilever (HUVR) 1QFY22 result was in line with our estimates. Resiliency in demand for health, hygiene and nutrition portfolio helped HUL to protect decline in revenue growth (compared to 4QFY21) due to impact of 2nd wave induced lockdowns. Revenue from discretionary and out of home consumption portfolio impacted significantly. Demand from rural outperformed urban during the quarter. Positively HUL has taken 3% price hike in respective product portfolio to mitigate the impact of inflation. Further, premium portfolio is growing at 2x compared to other products; this should be more margin accretive. Management expects integration with GSK to be 100% complete by...

Hindustan Unilever Ltd (HUL) is India's largest FMCG player having ~44 brands spanning 14 distinct categories largely grouped into home care, beauty & personal care, food & refreshments & others.

Gaining market share: HUVR now has 14 brands with over INR10b in annual sales (v/s 12 brands last year). In FY21, it gained market share in 84% of its portfolio and launched more than 150 SKUs. Rapid technology adoption: A significant leap has been observed in technology adoption among small retailers, which are convinced that this is, indeed, the need of the hour. HUVR's eB2B app, Shikhar', has enabled its retailer partners to place contactless orders conveniently, with over 500k retailers ordering through the app. We reckon that while this accounts for ~20% of HUVR's direct...

Continued strong demand in Rural areas supported by decent urban demand recovery improves the outlook of the business in near-term. Despite uncertainty arising due to increase in COVID cases, we believe the company is well-placed in terms of demand planning & supply chain management. Therefore, we maintain our BUY rating on the stock with a target price of Rs. 2,710 based on 58x FY23E adj. EPS. Strong recovery in BPC, HC drives revenue growth HUVR's revenue grew by 34.6% YoY (+2.3% QoQ) to Rs. 12,132cr, supported by...

(accounting for 30.87% of total sales). Sales of Beauty & Personal Care segment has gone up GSKCH business, which was amalgamated with the company effective April 1, 2020. Sales of Others segment has gone up 112% to Rs 507.00 crore (accounting for 4.08% of total sales). Profit before interest, tax and other unallocable items (PBIT) has jumped 52% to Rs 2,777.00...

Though HUL saw strong growth momentum till the second week of April, second wave of Covid-19 started to impact discretionary categories again after localised lockdowns. We believe soaps, sanitisers & foods categories would continue to see robust growth in FY22E also with heightened hygiene preferences & increase in at-home consumption. Detergent, cosmetics &...

We believe, over the medium to long term HUL is poised to deliver a consistent and profitable volume led growth given execution, distribution and digital capabilities.